Amid criticism on its liberalised vaccine policy, the Centre on Saturday said the media reports suggesting inequities in the distribution of doses were “inaccurate...
The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V Covid-19...
While some countries are preparing to resume global travel, some people are discovering that their choice of vaccine could determine where they’re allowed to...
Ahmedabad-based Zydus Cadila can become India’s second indigenously-developed jab after Bharat Biotech’s Covaxin and fourth vaccine candidate as they are likely to apply for...
Senior virologist Shahid Jameel quits from his chairman post of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a forum set up by the union government...
Covaxin has been found to be effective against coronavirus strains found in India and the UK, said Bharat Biotech on Sunday.
Citing a study published...
Amid the shortage of COVID-19 vaccines, especially the indigenously made Covaxin, the Centre and Hyderabad-based Bharat Biotech expressed willingness to let other companies produce...
The Union health ministry on Friday informed that a total of 1.92 crore doses of covid-19 vaccines--Covishield and Covaxin--will be supplied to states/UTs free...
